Orphan designation: volixibat potassium Treatment of primary sclerosing cholangitis, 26/02/2025 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 March 2025 - 10:42

Orphan designation: volixibat potassium Treatment of primary sclerosing cholangitis, 26/02/2025 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3029

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters